Literature DB >> 24032723

Interleukin-6 level and gene polymorphism in spontaneous miscarriage.

M Drozdzik1, N Szlarb, M Kurzawski.   

Abstract

The aetiology of spontaneous miscarriage, the most common pregnancy complication, remains undefined. One of postulated factors involved in miscarriage pathology is interleukin 6 (IL-6). Therefore, the aim of the study was to evaluate IL-6 and interleukin 6 receptor (IL-6R) gene polymorphisms in patients with spontaneous miscarriage. One hundred fifty-seven patients diagnosed with spontaneous miscarriage and age and gestational time matched controls were included in the case-control study. In all study participants circulating IL-6 levels (chemiluminescent immunoassay) and IL6-174G>C as well as IL6R rs2228145:A>C polymorphisms were evaluated. The distribution of IL6 as well as IL6R alleles and genotypes were similar in the controls and patients with miscarriage. Only a trend of more frequent appearance of -174GC+CC and C allele in the patients with miscarriage was noted. Blood serum concentrations of IL-6 were significantly elevated in patients with miscarriage vs those with physiological pregnancy. Likewise, IL-6 concentrations differ significantly with the types of miscarriage. The highest concentrations of the cytokine was seen in subjects with incomplete miscarriage (4.28 ± 4.88 pg/ml) followed by imminent miscarriage (2.97 ± 2.42 pg/ml), and then missed miscarriage (2.07 ± 1.90 pg/ml), being significantly the lowest in missed miscarriage group. No association between the IL6 genotype and IL-6 serum concentration were noted, both in the miscarriage group and in the control group. The findings of the study support the role of IL-6 in spontaneous miscarriage irrespectively of its type. However, no correlation between circulating IL-6 and IL6 gene polymorphism, as well as IL-6 and IL-6R polymorphisms associations with spontaneous miscarriage were revealed.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  IL-6 receptor; IL6; IL6R; gene polymorphism; interleukin-6; spontaneous miscarriage

Mesh:

Substances:

Year:  2013        PMID: 24032723     DOI: 10.1111/tan.12179

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  6 in total

1.  Role of IL-6 -174(G/C) promoter polymorphism in the etiology of early-onset preeclampsia.

Authors:  Sabnavis Sowmya; Aruna Ramaiah; Pratibha Nallari; Akka Jyothy; Ananthapur Venkateshwari
Journal:  Inflamm Res       Date:  2015-04-28       Impact factor: 4.575

Review 2.  Association between Genetic Polymorphisms in Interleukin Genes and Recurrent Pregnancy Loss - A Systematic Review and Meta-Analysis.

Authors:  Meixiang Zhang; Jiawei Xu; Xiao Bao; Wenbin Niu; Linlin Wang; Linqing Du; Nan Zhang; Yingpu Sun
Journal:  PLoS One       Date:  2017-01-19       Impact factor: 3.240

3.  Interleukin-3 Polymorphism is Associated with Miscarriage of Fresh in Vitro Fertilization Cycles.

Authors:  Cheng-Hsuan Wu; Tsung-Hsien Lee; Shun-Fa Yang; Hui-Mei Tsao; Yu-Jun Chang; Chia-Hsuan Chou; Maw-Sheng Lee
Journal:  Int J Environ Res Public Health       Date:  2019-03-19       Impact factor: 3.390

4.  Associations between tumor necrosis factor-α and interleukin-6 polymorphisms and unexplained recurrent spontaneous abortion risk: A meta-analysis.

Authors:  Xiaoxuan Zhao; Yuepeng Jiang; Yunlu Ping; Hongwei Guo; Meirong He; Xiaoling Feng
Journal:  Medicine (Baltimore)       Date:  2019-11       Impact factor: 1.817

5.  Cross-sectional study of chromosomal aberrations and immunologic factors in Iraqi couples with recurrent pregnancy loss.

Authors:  Doaa A Khamees; Mushtak T S Al-Ouqaili
Journal:  PeerJ       Date:  2022-02-07       Impact factor: 2.984

6.  Effect of interleukin 6 -174G>C gene polymorphism on opioid requirements after total hip replacement.

Authors:  Monika Białecka; Alina Jurewicz; Anna Machoy-Mokrzyńska; Mateusz Kurzawski; Katarzyna Leźnicka; Violetta Dziedziejko; Krzysztof Safranow; Marek Droździk; Andrzej Bohatyrewicz
Journal:  J Anesth       Date:  2016-04-05       Impact factor: 2.078

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.